Contact information
Sasha Maronova (preferred contact)
sasha.maronova@cmd.ox.ac.uk
https://orcid.org/0000-0002-8950-7646
NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ UK
Paul Brennan
PhD, FRSC
Professor of Medicinal Chemistry
- Director – Centre for Medicines Discovery
- Director of Chemistry – Chemical Probes Portal
My research group works at the interface of chemistry and biology to design probes and inhibitors to investigate the intricate workings of human proteins and cells, with particular interest in epigenetic proteins, small GTPases, and dementia. Research interests include medicinal chemistry, fragment- and structure-based drug design, computational chemistry, organic synthesis, and biochemistry. The group is part of the Alzheimer's Research UK Oxford Drug Discovery Institute (ODDI), and Centre for AI in Precision Medicine at the University of Oxford.
More Information
Recent publications
Chemical probes for Alzheimer’s disease targets
Journal article
Aiken SG. et al, (2026), Essays in Biochemistry
The KDM6 histone H3K27me3 demethylase inhibitor GSK-J4 induces metal and stress responses in multiple myeloma cells.
Journal article
Cribbs AP. et al, (2026), RSC Chem Biol
Inhibition of MLLT1 limits growth of KMT2A::AFF1 leukaemias without killing healthy haematopoietic stem cells.
Journal article
Rajhansa S. et al, (2026), Experimental hematology
KDM3A catalyses the oxidation of acetyl-lysine to hydroxyacetyl-lysine on histone H3K9.
Journal article
Belle R. et al, (2026), Nature chemistry, 18, 823 - 834
Pleural fluid neutrophil extracellular traps are associated with disease severity and risk of one-year mortality in pleural infection. An observational, international, multicohort study (TORPIDS-3).
Journal article
Chu JY. et al, (2026), The European respiratory journal

